Price Alert

Artelo Biosciences Inc. (ARTL)

NASDAQ: ARTL · Real-Time Price · USD

10.06

-0.03 (-0.30%)

At close: Aug 15, 2025, 3:49 PM

10.25

1.89%

After-hours: Aug 15, 2025, 07:49 PM EDT

Artelo Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Nov 30, 2021	Aug 31, 2021	May 31, 2021	Feb 28, 2021
Cash & Equivalents	2.07M	746K	2.34M	4.36M	881K	1.2M	2.81M	2.64M	5.72M	6.92M	6.89M	7.14M	12.12M	10.35M	12.16M	6.63M	10.05M	10.71M
Short-Term Investments	n/a	n/a	n/a	500K	4.72M	6.41M	7.61M	10.22M	8.27M	8.57M	10.64M	12.35M	9.2M	13.16M	11.95M	3.44M	n/a	512.03K
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-1.5M	-1.49M	-1.99M	n/a	1.52M	n/a	n/a	n/a
Other Long-Term Assets	3K	3K	3K	3K	3K	3K	3K	-0.00	197K	3K	3K	3K	3K	3K	3K	189K	n/a	n/a
Receivables	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2M	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-4M	n/a	n/a	n/a	n/a
Other Current Assets	167K	636K	219K	129K	566K	579K	554K	10.79M	611K	903K	789K	2.31M	2.95M	3.08M	514K	252K	248K	186.74K
Total Current Assets	2.23M	1.38M	2.56M	4.99M	6.17M	8.19M	10.98M	13.43M	14.6M	16.39M	18.32M	20.3M	22.28M	24.59M	24.61M	10.32M	10.3M	11.41M
Property-Plant & Equipment	82K	91K	99K	108K	116K	124K	21K	29K	39K	50K	60K	70K	81K	73K	81K	90K	63.00	124.00
Goodwill & Intangibles	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M	2.04M
Total Long-Term Assets	2.12M	2.13M	2.14M	2.15M	2.16M	2.17M	2.06M	2.07M	2.27M	2.09M	2.1M	2.11M	2.12M	2.12M	3.64M	2.32M	2.04M	2.04M
Total Assets	4.36M	3.52M	4.7M	7.14M	8.33M	10.35M	13.04M	15.5M	16.88M	18.48M	20.42M	22.41M	24.41M	26.7M	28.25M	12.63M	12.34M	13.44M
Account Payables	n/a	2.51M	1.68M	627K	863K	607K	1.24M	840K	523K	701K	905K	411K	432K	800K	975K	493K	418.94K	583.97K
Deferred Revenue	n/a	236K	n/a	n/a	n/a	n/a	n/a	-32K	-523K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	845K	n/a	n/a	n/a	n/a	n/a	n/a	32K	34K	37K	40K	42K	45K	32K	31K	28K	n/a	n/a
Other Current Liabilities	4.87M	n/a	-3K	n/a	n/a	n/a	n/a	49K	569K	87K	53K	27K	50K	43K	21K	5K	5K	5K
Total Current Liabilities	5.71M	2.8M	1.77M	697K	940K	721K	1.29M	921K	603K	825K	998K	480K	527K	875K	1.03M	526K	423.94K	588.97K
Long-Term Debt	51K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	6K	15K	23K	32K	40K	49K	57K	67K	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	418.94K	583.97K
Total Long-Term Liabilities	51K	59K	69K	78K	87K	96K	n/a	n/a	6K	15K	23K	32K	40K	49K	57K	67K	418.94K	583.97K
Total Liabilities	5.76M	2.86M	1.84M	775K	1.03M	817K	1.29M	921K	609K	840K	1.02M	512K	567K	924K	1.08M	593K	423.94K	588.97K
Total Debt	896K	95K	104K	112K	120K	127K	23K	32K	40K	52K	63K	74K	85K	81K	88K	95K	n/a	n/a
Common Stock	1K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	3K	42K	42K	42K	25K	23.15K	22.21K
Retained Earnings	-55.73M	-52.51M	-50.14M	-46.36M	-45.23M	-42.79M	-40.31M	-37.24M	-34.79M	-33.19M	-31.02M	-27.68M	-25.35M	-22.9M	-20.94M	-16.9M	-15.02M	-12.77M
Comprehensive Income	-295K	-227K	-202K	-218K	-203K	-203K	-203K	-199K	-201K	-205K	-254K	-388K	-176K	-64K	-18K	18K	49.38K	47.9K
Shareholders Equity	-1.41M	652K	2.86M	6.36M	7.3M	9.54M	11.75M	14.58M	16.27M	17.64M	19.4M	21.9M	23.84M	25.78M	27.17M	12.04M	11.92M	12.86M
Total Investments	n/a	n/a	n/a	500K	4.72M	6.41M	7.61M	10.22M	8.27M	8.57M	9.15M	10.86M	7.21M	13.16M	12.32M	3.44M	n/a	512.03K